179 related articles for article (PubMed ID: 19118051)
1. Advancing bioluminescence imaging technology for the evaluation of anticancer agents in the MDA-MB-435-HAL-Luc mammary fat pad and subrenal capsule tumor models.
Zhang C; Yan Z; Arango ME; Painter CL; Anderes K
Clin Cancer Res; 2009 Jan; 15(1):238-46. PubMed ID: 19118051
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
Fricke IB; De Souza R; Costa Ayub L; Francia G; Kerbel R; Jaffray DA; Zheng J
PLoS One; 2018; 13(5):e0196892. PubMed ID: 29723251
[TBL] [Abstract][Full Text] [Related]
3. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive visualization of tumor growth in a human colorectal liver metastases xenograft model using bioluminescence in vivo imaging.
Thalheimer A; Korb D; Bönicke L; Wiegering A; Mühling B; Schneider M; Koch S; Riedel SS; Germer CT; Beilhack A; Brändlein S; Otto C
J Surg Res; 2013 Nov; 185(1):143-51. PubMed ID: 23998649
[TBL] [Abstract][Full Text] [Related]
5. Multimodality imaging assessments of response to metformin therapy for breast cancer in nude mice.
Mao Y; Xia R; Wang L; Wang YQ; Gao FB
Chin Med J (Engl); 2013; 126(19):3717-22. PubMed ID: 24112170
[TBL] [Abstract][Full Text] [Related]
6. Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis.
Jenkins DE; Oei Y; Hornig YS; Yu SF; Dusich J; Purchio T; Contag PR
Clin Exp Metastasis; 2003; 20(8):733-44. PubMed ID: 14713107
[TBL] [Abstract][Full Text] [Related]
7. Antimetastatic and anticancer activity of S-1, a new oral dihydropyrimidine-dehydrogenase-inhibiting fluoropyrimidine, alone and in combination with paclitaxel in an orthotopically implanted human breast cancer model.
Nukatsuka M; Fujioka A; Nakagawa F; Oshimo H; Kitazato K; Uchida J; Sugimoto Y; Nagayama S; Fukushima M
Int J Oncol; 2004 Dec; 25(6):1531-6. PubMed ID: 15547687
[TBL] [Abstract][Full Text] [Related]
8. Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice.
Kim S; Zhang Y; Tang S; Qin C; Karelia D; Sharma A; Jiang C; Lu J
Prostate; 2019 Jun; 79(9):949-960. PubMed ID: 30958914
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
[TBL] [Abstract][Full Text] [Related]
10. Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model.
Vantyghem SA; Wilson SM; Postenka CO; Al-Katib W; Tuck AB; Chambers AF
Cancer Res; 2005 Apr; 65(8):3396-403. PubMed ID: 15833874
[TBL] [Abstract][Full Text] [Related]
11. Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro.
Rose DP; Connolly JM; Liu XH
Cancer Res; 1994 Dec; 54(24):6557-62. PubMed ID: 7987856
[TBL] [Abstract][Full Text] [Related]
12. Preclinical study of prolonged administration of trastuzumab as combination therapy after disease progression during trastuzumab monotherapy.
Fujimoto-Ouchi K; Sekiguchi F; Yamamoto K; Shirane M; Yamashita Y; Mori K
Cancer Chemother Pharmacol; 2010 Jul; 66(2):269-76. PubMed ID: 19904537
[TBL] [Abstract][Full Text] [Related]
13. Human embryonic stem cell-derived endothelial cells as cellular delivery vehicles for treatment of metastatic breast cancer.
Su W; Wang L; Zhou M; Liu Z; Hu S; Tong L; Liu Y; Fan Y; Kong D; Zheng Y; Han Z; Wu JC; Xiang R; Li Z
Cell Transplant; 2013; 22(11):2079-90. PubMed ID: 23067802
[TBL] [Abstract][Full Text] [Related]
14. [Establishment of a bioluminescent MDA-MB-231 cell line for in vivo imaging of human triple-negative breast cancer xenograft].
Wang K; Xie SM; He JJ; Ren Y; Xia HB; Zhang XW
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1812-8. PubMed ID: 22126756
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice.
Huang X; Bennett M; Thorpe PE
Cancer Res; 2005 May; 65(10):4408-16. PubMed ID: 15899833
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive visualization of retinoblastoma growth and metastasis via bioluminescence imaging.
Ji X; Cheng L; Wei F; Li H; Wang M; Tian Y; Chen X; Wang Y; Wolf F; Li C; Huang Q
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5544-51. PubMed ID: 19608529
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
Li C; Price JE; Milas L; Hunter NR; Ke S; Yu DF; Charnsangavej C; Wallace S
Clin Cancer Res; 1999 Apr; 5(4):891-7. PubMed ID: 10213226
[TBL] [Abstract][Full Text] [Related]
18. Bioluminescence imaging correlates with tumor serum marker, organ weights, histology, and human DNA levels during treatment of orthotopic tumor xenografts with antibodies.
Poeschinger T; Renner A; Weber T; Scheuer W
Mol Imaging Biol; 2013 Feb; 15(1):28-39. PubMed ID: 22528864
[TBL] [Abstract][Full Text] [Related]
19. Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer.
Scatena CD; Hepner MA; Oei YA; Dusich JM; Yu SF; Purchio T; Contag PR; Jenkins DE
Prostate; 2004 May; 59(3):292-303. PubMed ID: 15042605
[TBL] [Abstract][Full Text] [Related]
20. Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.
Seitz S; Rick FG; Schally AV; Treszl A; Hohla F; Szalontay L; Zarandi M; Ortmann O; Engel JB; Buchholz S
Oncol Rep; 2013 Jul; 30(1):413-8. PubMed ID: 23624870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
